Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·33 episodes·Last published 6mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHost
Recent guests
Recent episodes
Episode 33: The emotional toll of VTE: A patient’s perspective
Dec 4, 2025
25m 05s
Episode 32: 2025 breakthroughs in VTE and AF
Nov 26, 2025
26m 46s
Episode 31: Optimising treatment duration for thrombosis
Oct 10, 2025
25m 56s
Episode 30: VTE and AF at ESC 2025
Sep 10, 2025
36m 15s
Episode 29: Individualised care in special populations
Mar 18, 2025
19m 41s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 12/4/25 | Episode 33: The emotional toll of VTE: A patient’s perspective✨ | VTEpatient experience+4 | Leslie Lake | National Blood Clot Alliance | — | VTEpulmonary embolism+5 | — | 25m 05s | |
| 11/26/25 | Episode 32: 2025 breakthroughs in VTE and AF✨ | VTE managementAF management+4 | Dr Behnood Bikdeli | API-CATRENOVE+4 | — | VTEAF+8 | — | 26m 46s | |
| 10/10/25 | Episode 31: Optimising treatment duration for thrombosis✨ | anticoagulation therapythrombosis treatment+3 | Dr Deborah SiegalDr Barnes | medthority | — | thrombosisanticoagulation+3 | — | 25m 56s | |
| 9/10/25 | Episode 30: VTE and AF at ESC 2025✨ | VTEAF+4 | Dr Marco Proietti | AMALFIALONE-AF+1 | — | VTEAF+6 | — | 36m 15s | |
| 3/18/25 | Episode 29: Individualised care in special populations✨ | individualised carethrombosis prevention+5 | Dr Steven DeitelzweigDr Barnes | medthority | — | thrombosisbleed risk+5 | — | 19m 41s | |
| 3/6/25 | Episode 28: Real-world evidence: Addressing gaps in VTE and AF clinical research✨ | real-world evidenceVTE+5 | Dr Steven Deitelzweig | medthority | — | real-world evidenceVTE+7 | — | 20m 01s | |
| 2/18/25 | Episode 27: A multidisciplinary approach to CAT✨ | cancervenous thromboembolism+4 | Dr Marc CarrierDr Geoffrey Barnes | medthority | — | cancer diagnosisVTE+5 | — | 15m 09s | |
| 2/4/25 | Episode 26: From pragmatic trials to everyday treatment – DOACs for CAT✨ | anticoagulationpragmatic trials+4 | Dr Marc Carrier | CANVASRENOVE+1 | — | anticoagulationDOACs+5 | — | 19m 36s | |
| 1/21/25 | Episode 25: AF and CKD – A “tight association”✨ | chronic kidney diseaseatrial fibrillation+4 | Dr PiazzaDr Barnes | medthorityEpisode 25: AF and CKD – A “tight association” | — | chronic kidney diseaseatrial fibrillation+5 | — | 23m 20s | |
| 1/7/25 | Episode 24: Clinical considerations: Managing treatment switches✨ | anticoagulantstreatment switches+3 | Dr Arthur Allen | medthority | — | anticoagulantstreatment switches+5 | — | 20m 55s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 12/18/24 | Episode 23: From hospital to community: Transitions in VTE care | Dr Piazza and Dr Barnes discuss how collaboration and a clear message can ease the transition from hospital to home, and the return to daily routines, for people recovering from VTE. Our experts discuss the optimal timing of thrombophilia testing, supporting medication adherence and getting patients moving again. | 20m 58s | ||||||
| 12/3/24 | Episode 22: Selecting anticoagulants: Individualised approaches | “We can definitely utilise each other’s strengths and expertise and make some synergy. We all have the same goal here.” Clinical pharmacist Dr Sara Vazquez and Dr Barnes discuss how physicians and pharmacists can collaborate to create more effective, individualised treatment approaches, and outline strategies to ensure patients are meaningfully involved in decisions about their treatment. | 14m 30s | ||||||
| 11/20/24 | Episode 21: Optimising adherence in anticoagulation therapy | Dr Barnes and Dr Sara Vazquez consider the diverse factors that influence patients’ adherence to anticoagulant therapy, including “nuisance bleeding”, pill burden, and whether treatment is to prevent AF or VTE. They also look at different ways to build habits that can work for different individuals, and Dr Vazquez offers practical tips for effective communication with patients about their medications. | 16m 54s | ||||||
| 8/22/24 | Episode 20: “If you measure it, you can improve it” – AI for managing AF | Artificial intelligence (AI) in cardiovascular care is empowering researchers and clinicians to uncover new findings that were previously undetectable. These data enable more sophisticated conclusions for guiding clinical decision-making. Dr Rohan Khera joins Dr Barnes to examine the present and future impact of AI technologies on the management of AF. | 16m 40s | ||||||
| 8/22/24 | Episode 19: Does obesity positively impact direct oral anticoagulation outcomes? | Dr Barnes and Dr Karlyn Martin discuss how recent data have informed opinions on the safety and efficacy of using direct oral anticoagulants (DOAC) in people with obesity and thrombosis. Dr Martin considers DOACs for people who have received bariatric surgery, and if guidelines for DOAC use in patients with comorbid obesity and VTE apply to other groups with thrombosis. | 21m 20s | ||||||
| 7/29/24 | Episode 18: “Can’t I just use an aspirin instead?” | Host Dr Geoffrey Barnes and Dr Sara Vazquez review treatment options for stroke prevention in patient groups with AF and discuss overcoming patient and physician barriers to initiating optimal treatment. Dr Barnes observes: “Patients will often bring interesting stories that influence their ability to make a decision.” | 20m 13s | ||||||
| 7/22/24 | Episode 17: Anticoagulation for atrial fibrillation and comorbid obesity | Dr Geoffrey Barnes and Dr Gregory Piazza examine when ongoing weight-adjusted dosages are necessary in a patient with AF and obesity, best practices for monitoring renal function and medication levels, and specific lifestyle modifications. | 20m 54s | ||||||
| 7/3/24 | Episode 16: Stroke prevention in AF with high bleeding risk | Mitigating the risk of stroke in people with high bleeding risk can be a challenging balancing act. Dr Potpara and Dr Barnes discuss how these risks can be addressed, and how “patients should not be denied effective therapies because of concerns that can be managed in other ways”. | 22m 02s | ||||||
| 7/3/24 | Episode 15: Stroke prevention in older adults with AF | Dr Tatjana Potpara and Dr Barnes focus on managing stroke risk in older adults with AF, highlighting the clinical challenge of balancing bleeding risk with the benefits of anticoagulants. | 25m 27s | ||||||
| 6/6/24 | Episode 14: Wearables: Are they ready for the prime time? | Dr Jackson and Dr Barnes take a closer look at the hot topic of wearable devices in AF detection – their potential benefits and limitations – and how physicians can best discuss wearables with their patients. | 19m 23s | ||||||
| 6/6/24 | Episode 13: Patient case study: Older and frail adult with AF at high risk of bleeding | Dr Larry Jackson and Dr Barnes consider how best to tackle a patient case study with a focus on optimal management of AF in older patients at high risk of bleeding. | 19m 01s | ||||||
| 5/2/24 | Episode 12: Unravelling AF and comorbidities | Dr Barnes and Dr Frederik Verbrugge take a closer look at the management of stroke risk in people with AF and comorbid conditions. | 23m 56s | ||||||
| 5/2/24 | Episode 11: Real-world evidence: Anticoagulation strategies for CAT | “There’s no doubt that pharmacological prophylaxis is under used.” Dr Carrier and Dr Barnes discuss the real-world evidence underpinning strategy for the management of CAT. | 22m 28s | ||||||
| 5/2/24 | Episode 10: Cancer heterogeneity and CAT | Dr Marc Carrier and Dr Barnes discuss the challenges posed by cancer heterogeneity when managing CAT. | 21m 43s | ||||||
| 3/19/24 | Episode 9: Unmet medical needs in AF management | Dr Proietti and Professor Lip highlight unmet needs in AF management for stroke prevention and their prevalence among people with AF. | 15m 30s | ||||||
Showing 25 of 33
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.